Zacks: Brokerages Anticipate Trupanion Inc (TRUP) Will Post Quarterly Sales of $91.29 Million
Equities analysts forecast that Trupanion Inc (NASDAQ:TRUP) will post sales of $91.29 million for the current fiscal quarter, according to Zacks Investment Research. Three analysts have issued estimates for Trupanion’s earnings, with the highest sales estimate coming in at $91.37 million and the lowest estimate coming in at $91.20 million. Trupanion reported sales of $73.39 million during the same quarter last year, which indicates a positive year over year growth rate of 24.4%. The company is scheduled to report its next quarterly earnings results on Thursday, August 1st.
According to Zacks, analysts expect that Trupanion will report full-year sales of $373.55 million for the current year, with estimates ranging from $372.30 million to $374.55 million. For the next year, analysts forecast that the company will post sales of $442.25 million, with estimates ranging from $436.30 million to $449.05 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research firms that cover Trupanion.
Trupanion (NASDAQ:TRUP) last announced its earnings results on Thursday, May 2nd. The financial services provider reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.03). Trupanion had a negative return on equity of 0.59% and a negative net margin of 0.23%. The company had revenue of $86.98 million during the quarter, compared to analysts’ expectations of $85.87 million. During the same quarter last year, the firm posted ($0.05) earnings per share. The firm’s revenue was up 24.7% on a year-over-year basis.
In related news, CRO Margaret Tooth sold 1,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 21st. The shares were sold at an average price of $29.73, for a total value of $29,730.00. Following the sale, the executive now owns 4,693 shares in the company, valued at $139,522.89. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Asher Bearman sold 10,300 shares of the firm’s stock in a transaction that occurred on Friday, March 29th. The stock was sold at an average price of $32.58, for a total transaction of $335,574.00. Following the completion of the sale, the insider now owns 8,191 shares in the company, valued at approximately $266,862.78. The disclosure for this sale can be found here. Insiders have sold 104,503 shares of company stock valued at $3,299,613 in the last three months. 13.61% of the stock is owned by insiders.
Hedge funds have recently modified their holdings of the stock. Victory Capital Management Inc. boosted its holdings in Trupanion by 5.9% in the fourth quarter. Victory Capital Management Inc. now owns 19,840 shares of the financial services provider’s stock worth $505,000 after purchasing an additional 1,105 shares during the last quarter. State of New Jersey Common Pension Fund D boosted its holdings in Trupanion by 26.3% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 480,000 shares of the financial services provider’s stock worth $12,221,000 after purchasing an additional 100,000 shares during the last quarter. Phoenician Capital LLC purchased a new stake in Trupanion in the fourth quarter worth approximately $3,355,000. Tokio Marine Asset Management Co. Ltd. boosted its holdings in Trupanion by 17.5% in the fourth quarter. Tokio Marine Asset Management Co. Ltd. now owns 12,100 shares of the financial services provider’s stock worth $308,000 after purchasing an additional 1,800 shares during the last quarter. Finally, Royce & Associates LP boosted its holdings in Trupanion by 11.4% in the fourth quarter. Royce & Associates LP now owns 330,392 shares of the financial services provider’s stock worth $8,412,000 after purchasing an additional 33,692 shares during the last quarter. Institutional investors own 95.66% of the company’s stock.
NASDAQ TRUP traded down $0.04 during trading on Monday, hitting $29.95. 206,288 shares of the company’s stock traded hands, compared to its average volume of 263,575. The company has a quick ratio of 1.85, a current ratio of 1.85 and a debt-to-equity ratio of 0.14. The firm has a market cap of $1.03 billion, a price-to-earnings ratio of -998.33 and a beta of 1.15. Trupanion has a 12-month low of $22.38 and a 12-month high of $46.70.
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Read More: What is the Fibonacci sequence?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.